TrialRheumatology (Oxford, England)2025

Baricitinib for Takayasu arteritis refractory to TNF-α inhibitors: a multicentre, single-arm trial.

Jiachen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.